E-LIB Suche - Ergebnisse für: Uruena, Analia

1

Epidemiology of Dengue in Argentina during the 2010/11 to 2..:

Rapaport, Solana ; Mauriño, Mariana ; Morales, María Alejandra...
Tropical Medicine and Infectious Disease. 9 (2024) 2 - p. 45 , 2024

Link: https://doi.org/10.3390/..

2

The economic rationale for cell-based influenza vaccines in..:

Fisman, David ; Giglio, Norberto ; Levin, Myron J....
Human Vaccines & Immunotherapeutics. 20 (2024) 1 - p. , 2024

Link: https://doi.org/10.1080/..

3

Meningococcal burden of disease in Argentina: 10 years epid..:

Neyro, Silvina ; Urueña, Analia ; Efron, Adriana...
Human Vaccines & Immunotherapeutics. 19 (2023) 2 - p. , 2023

Link: https://doi.org/10.1080/..

4

Opinions, Attitudes and Factors Related to SARS-CoV-2 Vacci..:

Urueña, Analía ; Machado, Ricardo ; Cunha, Juarez...
Vaccines. 11 (2023) 11 - p. 1660 , 2023

Link: https://doi.org/10.3390/..

5

1166. The Cost-Effectiveness Evidence of Enhanced Influenza..:

Giglio, David FismanNorberto ; Márquez-Peláez, Sergio ; Nguyen, Van...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

6

Real-World Evidence in Cost-Effectiveness Analysis of Enhan..:

Postma, Maarten ; Fisman, David ; Giglio, Norberto...
Vaccines. 11 (2023) 6 - p. 1089 , 2023

Link: https://doi.org/10.3390/..

7

2047. Meningococcal burden of disease in Argentina: 10 year..:

Urueña, Analia ; Neyro, Silvina ; Efron, Adriana...
Open Forum Infectious Diseases. 9 (2022) Supplement_2 - p. , 2022

Link: https://doi.org/10.1093/..

8

Cost-Effectiveness Analysis of Cell Versus Egg-Based Season..:

Urueña, Analía ; Micone, Paula ; Magneres, María Cecilia...
Vaccines. 10 (2022) 10 - p. 1627 , 2022

Link: https://doi.org/10.3390/..

9

Cost-Effectiveness Analysis of Switching from Trivalent to ..:

Urueña, Analia ; Micone, Paula ; Magneres, Cecilia..
Vaccines. 9 (2021) 4 - p. 335 , 2021

Link: https://doi.org/10.3390/..

10

Prolonged Posttreatment Virologic Control and Complete Sero..:

Uruena, Analia ; Cassetti, Isabel ; Kashyap, Neena...
Open Forum Infectious Diseases. 8 (2020) 1 - p. , 2020

Link: https://doi.org/10.1093/..

11

Cost-effectiveness of introducing an MF59-adjuvanted trival..:

Nguyen, Van Hung ; Vizzotti, Carla ; Uruena, Analia...
Vaccine. 38 (2020) 20 - p. 3682-3689 , 2020

Link: https://doi.org/10.1016/..

12

1435. The Cost-Effectiveness of Vaccinating With an Adjuvan..:

Nguyen, Van ; Vizzotti, Carla ; Uruena, Analia...
Open Forum Infectious Diseases. 5 (2018) suppl_1 - p. S444-S444 , 2018

Link: https://doi.org/10.1093/..

13

Single-Dose Universal Hepatitis A Immunization in 1-Year-Ol..:

Urueña, Analia ; González, Jorge ; Carrega, Maria Eugenia Perez...
Open Forum Infectious Diseases. 4 (2017) suppl_1 - p. S320-S320 , 2017

Link: https://doi.org/10.1093/..

14

Adults' Vaccination in Argentina: First-Ever Assessment of ..:

Katz, Nathalia ; Stecher, Daniel ; Urueña, Analia...
Open Forum Infectious Diseases. 3 (2016) suppl_1 - p. , 2016

Link: https://doi.org/10.1093/..

15

Response to Orellano et al. regarding cost-utility analysis..:

Urueña, Analía ; Vizzotti, Carla ; San Juan, Jorge A.
Vaccine. 34 (2016) 28 - p. 3222 , 2016

Link: https://doi.org/10.1016/..